Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease

Gillis, K. , Stevens, K. K., Bell, E., Patel, R. K., Jardine, A. G. , Morris, S. T.W., Schneider, M. P., Delles, C. and Mark, P. B. (2018) Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease. Clinical Kidney Journal, 11(4), pp. 532-539. (doi: 10.1093/ckj/sfx158) (PMID:30094018) (PMCID:PMC6070083)

[img]
Preview
Text
154266.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial.

467kB

Abstract

Background: Premature cardiovascular disease in patients with chronic kidney disease (CKD) is not explained by traditional risk factors and oxidative stress may contribute via endothelial and vascular dysfunction. We investigated the effect of ascorbic acid on oxidative stress and vascular function in CKD patients compared with controls with hypertension (HTN). Methods: A crossover study of intravenous saline and ascorbic acid was conducted. Biomarkers of oxidative stress were measured, while pulse wave analysis and brachial flow-mediated dilatation were performed to assess large artery and endothelial function. Results: Twenty HTN and 30 CKD patients Stages 3–5 were recruited. Serum ascorbic acid was significantly lower in patients with CKD. In both groups, ascorbic acid significantly increased total antioxidant potential and superoxide. Asymmetric dimethylarginine (ADMA) was reduced significantly by ascorbic acid in the CKD group and on multivariate regression analysis, age and the presence of CKD were predictors of ADMA response to ascorbic acid. Although no effect on FMD was observed, central blood pressure and augmentation index were reduced significantly in both groups. Conclusions: Ascorbic acid has pro- and antioxidant effects, reducing central blood pressure and augmentation index in HTN and CKD. Ascorbic acid reduces serum ADMA in CKD, which may have longer-term benefits.

Item Type:Articles
Additional Information:This study was funded by the Glasgow Renal and Transplant Endowment fund.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Patel, Dr Rajan and Stevens, Dr Kate and Schneider, Dr Markus and Mark, Dr Patrick and Gillis, Dr Keith and Morris, Dr Scott and Delles, Professor Christian and Jardine, Professor Alan
Authors: Gillis, K., Stevens, K. K., Bell, E., Patel, R. K., Jardine, A. G., Morris, S. T.W., Schneider, M. P., Delles, C., and Mark, P. B.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Clinical Kidney Journal
Publisher:Oxford University Press
ISSN:2048-8505
ISSN (Online):2048-8513
Published Online:06 February 2018
Copyright Holders:Copyright © 2018 The Authors
First Published:First published in Clinical Kidney Journal 11(4):532-539
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record